POZEN Inc., headquartered in Chapel Hill, NC, is a progressive pharmaceutical company committed to addressing unmet medical needs and providing affordable medicines to patients and physicians.
Since its founding in 1996, POZEN has successfully created novel pharmacologic agents primarily for pain and pain-related conditions by combining existing drug therapies that result in superior patient outcomes. POZEN’s unique in-source business model has been proven with its success in gaining U.S. FDA approval of two self-invented products in two years—something almost no other small pharmaceutical company has achieved.
POZEN’s lead product PA32540 is a component of POZEN’s pipeline of cost-effective, integrated therapies that are designed to enable the full power of aspirin by reducing its GI damage—with the potential to benefit the millions of Americans who use aspirin for cardiovascular disease prevention. POZEN is seeking to secure a strategic license agreement with one or more partners by the end of 2012 to maximize the sales potential of PA32540.
Brean Murray Carret & Co LLC Life Sciences Summit November 14, 2011